Kailera Therapeutics, Inc. financial statements
Kailera Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 148.96M | EODHD |
| Cash and equivalents | USD 160.27M | EODHD |
| Total debt | USD 10.75M | EODHD |
Kailera Therapeutics, Inc. financials on 6ix · Kailera Therapeutics, Inc. on 6ix